Schrijnders, D., de Bock, G. H., Houweling, S. T., van Hateren, K. J. J., Groenier, K. H., Johnson, J. A., . . . Landman, G. W. D. (2017). Within-class differences in cancer risk for sulfonylurea treatments in patients with type 2 diabetes (ZODIAC-55) – a study protocol. BMC Cancer.
Citação norma ChicagoSchrijnders, Dennis, Geertruida H. de Bock, Sebastiaan T. Houweling, Kornelis J. J. van Hateren, Klaas H. Groenier, Jeffrey A. Johnson, Henk J. G. Bilo, Nanne Kleefstra, e Gijs W. D. Landman. "Within-class Differences in Cancer Risk for Sulfonylurea Treatments in Patients With Type 2 Diabetes (ZODIAC-55) – a Study Protocol." BMC Cancer 2017.
Citação norma MLASchrijnders, Dennis, et al. "Within-class Differences in Cancer Risk for Sulfonylurea Treatments in Patients With Type 2 Diabetes (ZODIAC-55) – a Study Protocol." BMC Cancer 2017.